Haeckel R, Oellerich M
Horm Metab Res. 1979 Nov;11(11):606-11. doi: 10.1055/s-0028-1092786.
The two hydrazone-compounds 2-(phenylethylhydrazono)-propionic acid (PEHP) and 2-(2-cyclohexyl-ethylhydrazono)-propionic acid (CHEHP) significantly lowered the blood glucose level in several laboratory animals fasted 48 hours (guinea pigs, mice, hamsters and rats). In the guinea pig, PEHP produced a three times stronger hypoglycemic effect than phenelzine, its corresponding hydrazine. Conversely both hydrazono compounds decreased the monoamine oxidase activity much less, than phenelzine. CHEHP (145 mumol/kg) inhibited this enzyme by less than 14%. After oral administration both hydrazones (200 mumol/kg) also produced a distinct hypoglycemic effect. The blood glucose lowering properties of the two hydrazones were most manifest in fasted guinea pigs, diabetic mice and rats with streptozotozin diabetes.
两种腙类化合物,即2-(苯乙腙基)-丙酸(PEHP)和2-(2-环己基-乙腙基)-丙酸(CHEHP),能显著降低禁食48小时的几种实验动物(豚鼠、小鼠、仓鼠和大鼠)的血糖水平。在豚鼠中,PEHP产生的降血糖作用比其相应的肼类药物苯乙肼强三倍。相反,两种腙类化合物对单胺氧化酶活性的降低作用比苯乙肼小得多。CHEHP(145μmol/kg)对该酶的抑制率不到14%。口服给药后,两种腙类化合物(200μmol/kg)也产生明显的降血糖作用。两种腙类化合物的降血糖特性在禁食的豚鼠、糖尿病小鼠和链脲佐菌素诱导糖尿病的大鼠中最为明显。